1. Home
  2. RZLT vs ORMP Comparison

RZLT vs ORMP Comparison

Compare RZLT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • ORMP
  • Stock Information
  • Founded
  • RZLT 2010
  • ORMP 2002
  • Country
  • RZLT United States
  • ORMP United States
  • Employees
  • RZLT N/A
  • ORMP N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLT Health Care
  • ORMP Health Care
  • Exchange
  • RZLT Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • RZLT 361.3M
  • ORMP N/A
  • IPO Year
  • RZLT N/A
  • ORMP N/A
  • Fundamental
  • Price
  • RZLT $4.82
  • ORMP $2.18
  • Analyst Decision
  • RZLT Strong Buy
  • ORMP Hold
  • Analyst Count
  • RZLT 6
  • ORMP 1
  • Target Price
  • RZLT $12.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • RZLT 1.4M
  • ORMP 77.2K
  • Earning Date
  • RZLT 05-13-2025
  • ORMP 08-15-2025
  • Dividend Yield
  • RZLT N/A
  • ORMP N/A
  • EPS Growth
  • RZLT N/A
  • ORMP N/A
  • EPS
  • RZLT N/A
  • ORMP N/A
  • Revenue
  • RZLT N/A
  • ORMP $2,000,000.00
  • Revenue This Year
  • RZLT $35.39
  • ORMP N/A
  • Revenue Next Year
  • RZLT N/A
  • ORMP N/A
  • P/E Ratio
  • RZLT N/A
  • ORMP N/A
  • Revenue Growth
  • RZLT N/A
  • ORMP 196.74
  • 52 Week Low
  • RZLT $2.22
  • ORMP $1.82
  • 52 Week High
  • RZLT $6.19
  • ORMP $3.09
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 67.57
  • ORMP 49.72
  • Support Level
  • RZLT $4.15
  • ORMP $2.10
  • Resistance Level
  • RZLT $4.71
  • ORMP $2.25
  • Average True Range (ATR)
  • RZLT 0.27
  • ORMP 0.09
  • MACD
  • RZLT 0.04
  • ORMP 0.00
  • Stochastic Oscillator
  • RZLT 89.36
  • ORMP 63.16

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: